To: | The Trustees of the Urban Pharmaceutical ETC. (jeannette@lutzker.com) |
Subject: | U.S. Trademark Application Serial No. 90752806 - FLANAX - 792.003 |
Sent: | February 22, 2022 03:12:56 PM |
Sent As: | ecom117@uspto.gov |
Attachments: | Attachment - 1 Attachment - 2 Attachment - 3 Attachment - 4 Attachment - 5 Attachment - 6 Attachment - 7 Attachment - 8 Attachment - 9 |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 90752806
Mark: FLANAX
|
|
Correspondence Address: |
|
Applicant: The Trustees of the Urban Pharmaceutical ETC.
|
|
Reference/Docket No. 792.003
Correspondence Email Address: |
|
NONFINAL OFFICE ACTION
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS). A link to the appropriate TEAS response form appears at the end of this Office action.
Issue date: February 22, 2022
The referenced application has been reviewed by the assigned trademark examining attorney. Applicant must respond timely and completely to the issue(s) below. 15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.
Section 2(d) Refusal – Likelihood Of Confusion
Applicant’s mark is FLANAX (in standard characters) for “antacids; cough lozenges; liniments; oral analgesics; topical analgesics; preparation for the relief of pain; analgesic balm; analgesic preparations; effervescent analgesic pharmaceutical preparations; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve” in Class 5.
Registrant’s mark is BELMORA LLC FLANAX (as a design mark) for “Antacids; Cough lozenges; Liniments; Preparation for the relief of pain” in Class 5.
Registrant’s mark is FLANAX (in standard characters) for “Antacids; Cough lozenges; Liniments” in Class 5.
Registrant’s mark is FLANAX MENSTRUAL PAIN RELIEVER (in standard characters) for “Orally ingestible tablets of Naproxen Sodium for use as an analgesic” in Class 5.
Although not all du Pont factors may be relevant, there are generally two key considerations in any likelihood of confusion analysis: (1) the similarities between the compared marks and (2) the relatedness of the compared goods and/or services. See In re i.am.symbolic, llc, 866 F.3d at 1322, 123 USPQ2d at 1747 (quoting Herbko Int’l, Inc. v. Kappa Books, Inc., 308 F.3d 1156, 1164-65, 64 USPQ2d 1375, 1380 (Fed. Cir. 2002)); Federated Foods, Inc. v. Fort Howard Paper Co.,544 F.2d 1098, 1103, 192 USPQ 24, 29 (C.C.P.A. 1976) (“The fundamental inquiry mandated by [Section] 2(d) goes to the cumulative effect of differences in the essential characteristics of the goods [or services] and differences in the marks.”); TMEP §1207.01.
Similarity of Marks
A likelihood of confusion exists here because the respective marks, FLANAX, BELMORA LLC FLANAX, FLANAX and FLANAX MENSTRUAL PAIN RELIEVER are highly similar in appearance, sound, connotation and overall impression.
Marks are compared in their entireties for similarities in appearance, sound, connotation, and commercial impression. Stone Lion Capital Partners, LP v. Lion Capital LLP, 746 F.3d 1317, 1321, 110 USPQ2d 1157, 1160 (Fed. Cir. 2014) (quoting Palm Bay Imps., Inc. v. Veuve Clicquot Ponsardin Maison Fondee En 1772, 396 F.3d 1369, 1371, 73 USPQ2d 1689, 1691 (Fed. Cir. 2005)); TMEP §1207.01(b)-(b)(v). “Similarity in any one of these elements may be sufficient to find the marks confusingly similar.” In re Inn at St. John’s, LLC, 126 USPQ2d 1742, 1746 (TTAB 2018) (citing In re Davia, 110 USPQ2d 1810, 1812 (TTAB 2014)), aff’d per curiam, 777 F. App’x 516, 2019 BL 343921 (Fed. Cir. 2019); TMEP §1207.01(b).
Here, the marks are similar in appearance and sound due to sharing the identical term FLANAX. Applicant’s mark FLANAX is identical to registrant’s mark FLANAX, and applicant’s deletion of the terms in the other registrations fails to obviate the likelihood of confusion present here, as applicant’s mark is likely to appear to prospective purchasers as a shortened form of registrant’s marks. See In re Mighty Leaf Tea, 601 F.3d 1342, 1348, 94 USPQ2d 1257, 1260 (Fed. Cir. 2010) (quoting United States Shoe Corp., 229 USPQ 707, 709 (TTAB 1985)). Thus, merely omitting some of the wording from a registered mark may not overcome a likelihood of confusion. See In re Mighty Leaf Tea, 601 F.3d 1342, 94 USPQ2d 1257; In re Optica Int’l, 196 USPQ 775, 778 (TTAB 1977); TMEP §1207.01(b)(ii)-(iii). In this case, applicant’s mark does not create a distinct commercial impression from the registered marks because it contains some of the wording in the registered marks and does not add any wording that would distinguish it from those marks.
As a result, because the marks are comprised in large part of the same or similar wording, they have a similar appearance, sound and connotation. Thus, these marks create a confusingly similar impression.
Comparison of Goods
A likelihood of confusion also exists because the parties’ goods are related. The goods and/or services are compared to determine whether they are similar, commercially related, or travel in the same trade channels. See Coach Servs., Inc. v. Triumph Learning LLC, 668 F.3d 1356, 1369-71, 101 USPQ2d 1713, 1722-23 (Fed. Cir. 2012); Herbko Int’l, Inc. v. Kappa Books, Inc., 308 F.3d 1156, 1165, 64 USPQ2d 1375, 1381 (Fed. Cir. 2002); TMEP §§1207.01, 1207.01(a)(vi).
The compared goods and/or services need not be identical or even competitive to find a likelihood of confusion. See On-line Careline Inc. v. Am. Online Inc., 229 F.3d 1080, 1086, 56 USPQ2d 1471, 1475 (Fed. Cir. 2000); Recot, Inc. v. Becton, 214 F.3d 1322, 1329, 54 USPQ2d 1894, 1898 (Fed. Cir. 2000); TMEP §1207.01(a)(i). They need only be “related in some manner and/or if the circumstances surrounding their marketing are such that they could give rise to the mistaken belief that [the goods and/or services] emanate from the same source.” Coach Servs., Inc. v. Triumph Learning LLC, 668 F.3d 1356, 1369, 101 USPQ2d 1713, 1722 (Fed. Cir. 2012) (quoting 7-Eleven Inc. v. Wechsler, 83 USPQ2d 1715, 1724 (TTAB 2007)); TMEP §1207.01(a)(i).
Here, applicant offers identical antacids, cough lozenges and liniments to the registrations for FLANAX and BELMORA LLC FLANAX. Further, applicant’s broadly identified oral analgesics encompass registrant’s more narrow orally ingestible tablets of Naproxen Sodium for use as an analgesic. Finally, applicant’s remaining goods are all closely related to registrant’s in that they are all pharmaceutical preparations similar in nature to registrant’s goods.
Accordingly, applicant’s and registrant’s goods are closely related for purposes of the Trademark Act.
Consequently, because the marks are similar in appearance, sound, connotation and convey a similar impression, and the goods are highly similar, consumers are likely to be confused as to their source. Therefore registration must be refused under Section 2(d) of the Trademark Act.
Claim Of Ownership Of Registrations
(1) Record the assignment with the USPTO’s Assignment Recordation Branch (ownership transfer documents such as assignments can be filed online at http://etas.uspto.gov) and promptly notify the trademark examining attorney that the assignment has been duly recorded;
(2) Submit copies of documents evidencing the chain of title; or
(3) Submit the following statement, verified with an affidavit or signed declaration under 37 C.F.R. §2.20: “Applicant is the owner of U.S. Registration No. 6074750, 6074745 and 5768512.” To provide this statement using the Trademark Electronic Application System (TEAS), use the “Response to Office Action” form; answer “yes” to wizard questions #3 and #9; then, continuing on to the next portion of the form, in the “Additional Statement(s)” section, find “Active Prior Registration(s)” and insert the U.S. registration numbers in the data fields; and follow the instructions within the form for signing. The form must be signed twice; a signature is required both in the “Declaration Signature” section and in the “Response Signature” section.
TMEP §812.01; see 15 U.S.C. §1060; 37 C.F.R. §§2.193(e)(1), 3.25, 3.73(a)-(b); TMEP §502.02(a).
Recording a document with the Assignment Recordation Branch does not constitute a response to an Office action. TMEP §503.01(d).
Applicant should note the following additional potential ground for refusal.
In response to this Office action, applicant may present arguments in support of registration by addressing the issue of the potential conflict between applicant’s mark and the mark in the referenced application. Applicant’s election not to submit arguments at this time in no way limits applicant’s right to address this issue later if a refusal under Section 2(d) issues.
The USPTO does not accept emails as responses to Office actions; however, emails can be used for informal communications and are included in the application record. See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05.
How to respond. Click to file a response to this nonfinal Office action.
/Amit K. Shoor/
Amit K. Shoor
Trademark Examining Attorney
Law Office 117, USPTO
571-272-7126
amit.shoor@uspto.gov
RESPONSE GUIDANCE